Bristol-Myers immunotherapy combo promising in melanoma: study

(Reuters) - A combination of two Bristol-Myers Squibb drugs that help the immune system fight melanoma led to significantly greater tumor shrinkage than treatment with one of the medicines, according to a midstage study presented on Monday.

from

• غرد
• مشاركة
• إضافة